Report Feb. 29 2024
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)Found: During the Covid-19 pandemic, the Health Protection (Coronavirus, Restrictions) (England) Regulations
Oral Evidence Feb. 28 2024
Inquiry: Emerging diseases and learnings from covid-19Found: She was previously deputy chief medical officer, including during the period of the pandemic.
Feb. 27 2024
Source Page: Supplementary Estimates 2023-24Found: includes, but is not exhaustive: NHS Test and Trace, personal protective equipment, Covid-19 medicines, treatments
Feb. 27 2024
Source Page: Supplementary Estimates 2023-24Found: includes, but is not exhaustive: NHS Test and Trace, personal protective equipment, Covid-19 medicines, treatments
Mentions:
1: Baroness Vere of Norbiton (Con - Life peer) The British Medical Association described it as“potentially transformative for the NHS”,because many - Speech Link
2: Lord Davies of Brixton (Lab - Life peer) abolition of the lifetime allowance would mean there would be 15,000 more people in work, not least in the medical - Speech Link
3: Lord Leigh of Hurley (Con - Life peer) They are two different sources of income and wealth, and therefore deserve different tax treatments, - Speech Link
4: Baroness Vere of Norbiton (Con - Life peer) The Government’s economic response to the coronavirus pandemic was made possible through the powerful - Speech Link
Feb. 19 2024
Source Page: Point prevalence survey on HCAI, AMU and AMS in EnglandFound: only be used when there is a clear history of allergy to penicillin; broad -spectrum second- line treatments
Feb. 06 2024
Source Page: Low earners and workplace pension saving – a qualitative studyFound: average, she works around 16 hours per week to have enough time and flexibility for her daughter’s medical
Mentions:
1: Lord Markham (Con - Life peer) The Medicines and Healthcare products Regulatory Agency—MHRA—is the UK regulator for medical devices, - Speech Link
2: Lord Markham (Con - Life peer) For example, for the next set of cancer treatments, it will be possible to take a sample of the malignant - Speech Link
Asked by: Andrew Bridgen (Independent - North West Leicestershire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the guidance by NICE entitled Covid-19 rapid guideline: managing symptoms (including at the end of life) in the community, NG163, published on 3 April 2020, which medical experts were consulted during the commissioning process.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The National Institute for Health and Care Excellence (NICE) guideline NG163, published in 2020, was commissioned in accordance with an established agreement between NHS England and NICE. The focus at that time was given to providing rapid guidance on the management of affected patients with COVID-19. The following organisations were consulted on the guideline:
- Association for Palliative Medicine;
- Palliative Care Formulary;
- Wolfson Palliative Care Research Centre;
- Cicely Saunders Institute;
- NHS England;
- ICU Steps;
- Macmillan Cancer Support;
- Marie Curie;
- National Audit for Care at the End of Life;
- Palliative Care for Wales;
- Royal College of General Practitioners;
- Royal College of Physicians; and
- Sue Ryder.
The following organisations provided general practice consultation on the guidance:
- NICE GP Reference Group; and
- RCGP Network.
A number of NICE’s COVID-19 rapid guidelines were subsequently incorporated into a single guideline, NG191, for the management of COVID-19 in children and adults. The list of panel members for this guideline is available at the following link:
https://www.nice.org.uk/guidance/ng191/documents/register-of-interests-2
Jan. 25 2024
Source Page: NHS England: annual report and accounts 2022 to 2023Found: the NHS remains at the forefront of innovation, with the introduction of several new cutting edge treatments